Literature DB >> 15210059

Effects of sodium beta-aescin on expression of adhesion molecules and migration of neutrophils after middle cerebral artery occlusion in rats.

Xia-min Hu1, Yan Zhang, Fan-dian Zeng.   

Abstract

AIM: To investigate the effects of sodium beta-aescin on neutrophil migration and expression of adhesion molecules (ICAM-1 and E-selectin) after middle cerebral artery occlusion (MCAO) in rats.
METHODS: Rats were pretreated with sodium beta-aescin for 7 d and then subjected to cerebral ischemia/reperfusion (I/R) injury induced by an MCAO. After a 2-h ischemia and a 24-h reperfusion, the infarct volume and neurological deficit were determined by the method of TTC staining and the Longa's score. The effect of sodium beta-aescin on the migration of neutrophils was evaluated by measuring the activity of myeloperoxidase (MPO) enzyme. The expressions of adhesion molecules were determined by immunohistochemistry and Western blot.
RESULTS: Sodium beta-aescin significantly reduced the cerebral infarct volume and ameliorated the neurological deficit (P<0.05 or P<0.01). The MPO activity and the expressions of ICAM-1 and E-selectin in the vehicle-treated rats were increased significantly (P<0.01) after cerebral I/R. After treatment with sodium beta-aescin, the enzymatic activity of MPO and the expressions of these adhesion molecules were significantly reduced compared with the vehicle-treated group (P<0.05 or P<0.01).
CONCLUSION: Sodium beta-aescin can attenuate brain injury, down-regulate the protein expressions of ICAM-1 and E-selectin, and reduce the migration of neutrophils after cerebral I/R.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15210059

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  8 in total

1.  N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Augments Thrombolysis of tPA (Tissue-Type Plasminogen Activator) in Aged Rats After Stroke.

Authors:  Chao Li; Li Zhang; Chunyang Wang; Hua Teng; Baoyan Fan; Michael Chopp; Zheng Gang Zhang
Journal:  Stroke       Date:  2019-08-07       Impact factor: 7.914

2.  Acteoside Presents Protective Effects on Cerebral Ischemia/reperfusion Injury Through Targeting CCL2, CXCL10, and ICAM1.

Authors:  Weijiang Wu; Gang Wu; Deyan Cao
Journal:  Cell Biochem Biophys       Date:  2021-01-13       Impact factor: 2.194

3.  The Effect of Pentoxifylline on bcl-2 Gene Expression Changes in Hippocampus after Ischemia-Reperfusion in Wistar Rats by a Quatitative RT-PCR Method.

Authors:  Soyar Sari; Mehrdad Hashemi; Reza Mahdian; Kazem Parivar; Mehdi Rezayat
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

4.  Endothelia-Targeting Protection by Escin in Decompression Sickness Rats.

Authors:  Kun Zhang; Zhongxin Jiang; Xiaowei Ning; Xuhua Yu; Jiajun Xu; Peter Buzzacott; Weigang Xu
Journal:  Sci Rep       Date:  2017-01-23       Impact factor: 4.379

5.  Curcumin prevents reperfusion injury following ischemic stroke in rats via inhibition of NF‑κB, ICAM-1, MMP-9 and caspase-3 expression.

Authors:  Wei Li; Nijasri Charnnarong Suwanwela; Suthiluk Patumraj
Journal:  Mol Med Rep       Date:  2017-08-10       Impact factor: 2.952

6.  Aescin Protects Neuron from Ischemia-Reperfusion Injury via Regulating the PRAS40/mTOR Signaling Pathway.

Authors:  Xinjie Gao; Heng Yang; Jiabin Su; Weiping Xiao; Wei Ni; Yuxiang Gu
Journal:  Oxid Med Cell Longev       Date:  2020-09-30       Impact factor: 6.543

7.  The Study of Pentoxifylline Drug Effects on Renal Apoptosis and BCL-2 Gene Expression Changes Following Ischemic Reperfusion Injury in Rat.

Authors:  Mehrdad Hashemi
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

Review 8.  Anti-Inflammation of Natural Components from Medicinal Plants at Low Concentrations in Brain via Inhibiting Neutrophil Infiltration after Stroke.

Authors:  Jiannan Chen; Xiangjian Zhang; Cong Zhang; Wenhui Wang; Rong Chen; Honglei Jiao; Linlin Li; Lan Zhang; Lili Cui
Journal:  Mediators Inflamm       Date:  2016-09-05       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.